Pioglitazone (PGZ), another PPARγ agonist that is structurally related to RGZ (41), was administered to mice challenged with PR8 and to cotton rats challenged with a non-adapted human strain of influenza to determine if providing the ligand for PPARγ could be protective against the strong inflammatory response elicited by influenza infection. The gene discussed is PPARG; the disease is influenza.